Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward.
about
Editorial: Current and Emerging Therapeutics in AD.Small-molecule PET Tracers for Imaging Proteinopathies.Insulin receptor sensitization restores neocortical excitation/inhibition balance in a mouse model of autism.α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β-stimulated murine astrocytesPreclinical progression of neurodegenerative diseases
P2860
Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Primary and Secondary Preventi ...... Looking Back, Moving Forward.
@en
Primary and Secondary Preventi ...... Looking Back, Moving Forward.
@nl
type
label
Primary and Secondary Preventi ...... Looking Back, Moving Forward.
@en
Primary and Secondary Preventi ...... Looking Back, Moving Forward.
@nl
prefLabel
Primary and Secondary Preventi ...... Looking Back, Moving Forward.
@en
Primary and Secondary Preventi ...... Looking Back, Moving Forward.
@nl
P2860
P1476
Primary and Secondary Preventi ...... Looking Back, Moving Forward.
@en
P2093
Gad A Marshall
P2860
P304
P356
10.2174/1567205013666160930112125
P577
2016-09-30T00:00:00Z